The Readout Loud

350 Avsnitt

1. 287: 2023 in review, CEO report cards, and a look at the year ahead

   Publicerades: 2023-12-21
2. 286: FTC v. biotech, Pfizer's kitchen sink, & Vertex's future

   Publicerades: 2023-12-14
3. 285: CRISPR history, biotech struggles, & a big week for deals

   Publicerades: 2023-12-07
4. 284: AbbVie’s big deal, CAR-T’s risks, & getting a biotech job

   Publicerades: 2023-11-30
5. 283: A CRISPR milestone, algorithms amok, & biotech mixology

   Publicerades: 2023-11-16
6. From Tradeoffs: Can the U.S. put an end to surprise ambulance bills?

   Publicerades: 2023-11-13
7. 282: Lilly’s obesity drug, the power of radiation, & a biotech implosion

   Publicerades: 2023-11-09
8. 281: Decoding biotech hype, the Sarepta saga, & au revoir to a CEO

   Publicerades: 2023-11-02
9. 280: ESMO highlights, Roivant's big deal, & biotech VC on the rise

   Publicerades: 2023-10-26
10. 279: Live from the 2023 STAT Summit

    Publicerades: 2023-10-19
11. 278: Merger Mondays, Ozempic panic, & CRISPR'd pigs

    Publicerades: 2023-10-12
12. 277: Is the Nobel committee evolving? Plus, preventing public health's wiliest virus

    Publicerades: 2023-10-05
13. 276: Who discovered GLP-1? Plus: BrainStorm at the FDA and biotech's slump

    Publicerades: 2023-09-28
14. 275: A thorny ALS debate at the FDA, and the promise of artificial wombs

    Publicerades: 2023-09-21
15. 274: Covid’s latest surge, Alnylam at the FDA, & the end of an era

    Publicerades: 2023-09-14
16. 273: Back to school for biotech, Biogen's potential pivot, & Illumina's next chapter

    Publicerades: 2023-09-07
17. 272: Vivek's star turn, leaky drug data, & biotech as family business

    Publicerades: 2023-08-24
18. 271: Racing for gene therapy, a pioneering approval, & startups in the lurch

    Publicerades: 2023-08-18
19. 270: Your guide to Wegovy’s blockbuster heart study

    Publicerades: 2023-08-10
20. 269: Biotech layoffs, eye drug drama, & gene therapy milestones

    Publicerades: 2023-08-03